Dr. Jason J. Luke, MD

  • Pittsburgh, PA
  • Hematologist and oncologist
NPI1093989196
Medicare services, 2024
154
Medicare patients, 2024
92
Part D claims, 2024
37
Publications
195
Clinical trials
17
Practice address
300 Halket St, Pittsburgh, PA 15213
Practice phone
Call (412) 432-5500
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UPMC Magee-Womens Hospital

Pittsburgh, Pennsylvania

See all 3 affiliations

Find Dr. Luke's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Jason J. Luke is a hematologist and oncologist in Pittsburgh, Pennsylvania

Dr. Luke practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania.

Dr. Luke's NPI, 1093989196, was assigned on April 18, 2008. Dr. Luke holds Pennsylvania license 33440115.

NPI and contact details
NPI enumeration date
April 18, 2008
NPI status
Active
Practice phone
(412) 432-5500
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Dr. Jason J. Luke practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania

Dr. Luke's primary practice is UPMC Magee-Womens Hospital, at 300 Halket St, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 432-5500.

  • UPMC Magee-Womens Hospital
    300 Halket St, Pittsburgh, PA 15213 · Allegheny CountyPhone(412) 432-5500

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Jason J. Luke is affiliated with 1 site of care and 2 medical groups

Dr. Luke's primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Luke to 1 more medical group, named with a free account.

See all 3 affiliations for Dr. Luke

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Jason J. Luke's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luke practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UPMC Magee-Womens HospitalAvailable with a free account
+1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Luke practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Jason J. Luke is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Dr. Luke's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Luke is board certified in medical oncology by the American Board of Internal Medicine. Dr. Luke is licensed in Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense 33440115 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Luke

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Jason J. Luke billed Medicare for 154 services in 2024

CMS data shows 154 Medicare services from Dr. Luke across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $15,076 for them.

Medicare services, 2024154
Medicare patients92
Paid by Medicare$15,076
Procedure codes3

Dr. Luke's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2112024: 15427%

Where Dr. Luke's Medicare services took place, 2024

  • In an office12782%
  • In a facility2718%

Dr. Luke compared with the Pennsylvania median for hematologists and oncologists, 2024

  • Dr. Luke
  • Pennsylvania median
Medicare services
154vs 65476% below
Medicare patients
92vs 22759% below
Part D claims
17vs 39396% below

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Luke's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Luke

Need commercial claims for Dr. Luke?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Luke and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Jason J. Luke treated 92 Medicare patients in 2024, average age 71

CMS counts 92 Medicare patients who saw Dr. Luke in 2024. The largest group is 65 to 74, with 53 patients. 59% of them have high blood pressure, and 57% have high cholesterol. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Luke's median patient age at 71, with 49% women.

Medicare patients, 202492
Average age71
Average risk score3.13

Dr. Luke's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Luke's Medicare patients by sex, 2024

  • Women3437%
  • Men5863%

Chronic conditions among Dr. Luke's Medicare patients, 2024

  1. High blood pressure59%
  2. High cholesterol57%
  3. Cancer49%
  4. Arthritis41%
  5. Ischemic heart disease39%
  6. Mood disorders28%
  7. Anxiety27%
  8. Depression26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Luke's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women49%
  • Men49%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Jason J. Luke wrote 37 Medicare Part D claims in 2024

In 2024, Dr. Luke wrote 37 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $132 in total drug cost. In 2017, CMS named 28 claims across 2 drugs.

Part D claims, 202437
Drugs named by CMS1
Total drug cost$132
Part D patients16

Dr. Luke's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2017 to 2019

  • 2017
  • 2019
Claims for drugs CMS names
2017: 282019: 1739%

Drugs named by CMS: 1 in 2019, 2 in 2017.

See all prescribing by Dr. Luke

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Jason J. Luke scored 81 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Luke for performance year 2024, reported as part of a group.

Dr. Luke's MIPS scores, performance year 2024

  • 81of 100Final score
  • 61.9of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Luke by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Jason J. Luke has 195 publications on record

Dmand AI links 195 papers to Dr. Luke, published from 2011 to 2025. 2024 was the busiest year, with 20. The most frequent topics are Melanoma, Immunotherapy and Skin Neoplasms. Dr. Luke has published most often in Clin Cancer Res. Dr. Luke's most frequent co-authors are Thomas F. Gajewski, Patrick Alexander Ott, MD and Steven J. Chmura.

Papers195
Years published2011 to 2025

Dr. Luke's papers by year, 2016 to 2025

Topics Dr. Luke writes about most

  • Melanoma
  • Immunotherapy
  • Skin Neoplasms
  • Antibodies, Monoclonal, Humanized
  • Immune Checkpoint Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Tumor Microenvironment
  • Ipilimumab

Dr. Luke's most frequent co-authors

Recent publications by Dr. Luke

See all 195 publications and co-authors

See who Dr. Luke researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Luke works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Jason J. Luke has worked on 17 clinical trials

Dmand AI links Dr. Luke to 17 clinical trials, 4 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Carcinoma, Renal Cell. Bristol-Myers Squibb sponsors the most, 3. Open Payments lists research payments to Dr. Luke that name 10 trials.

Clinical trials with Dr. Luke by phase

  1. 2Phase 1: 2 trials
  2. 1Phase 1/2: 1 trial
  3. 4Phase 2: 4 trials
  4. 1Phase 3: 1 trial
  5. NonePhase 4: no trials

Conditions in Dr. Luke's trials

  • Melanoma
  • Nevi and Melanomas
  • Carcinoma, Renal Cell
  • Squamous Cell Carcinoma of Head and Neck
  • Carcinoma, Merkel Cell

Investigators on the most trials with Dr. Luke

Recent clinical trials with Dr. Luke

See all 17 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Jason J. Luke received $451,592 in industry payments from 2016 to 2025

CMS Open Payments shows 429 general payments to Dr. Luke from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Merck Sharp & Dohme Corporation paid the most, $123,481. It also lists 26 research payments totaling $15,281 from 2016 to 2025, naming 10 clinical trials.

General payments to Dr. Luke by program year, 2016 to 2025

General payments to Dr. Luke by kind, 2016 to 2025

$451.6Kin total
  • Consulting fees$321,24871%
  • Travel and lodging$81,92618%
  • Speaker and faculty fees$25,4746%
  • Food and beverage$8,0592%
  • Other$13,9533%

Companies that paid Dr. Luke the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Luke

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Jason J. Luke is board certified in medical oncology

  1. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Jason J. Luke's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesClinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Jason J. Luke

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Jason J. Luke's NPI number?

Dr. Jason J. Luke's NPI number is 1093989196. It was assigned on April 18, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Jason J. Luke?

Dr. Jason J. Luke is a hematologist and oncologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Jason J. Luke practice?

Dr. Luke practices at 300 Halket St, Pittsburgh, PA 15213. Dr. Luke's primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. Dmand AI also links Dr. Luke to 1 medical group.

What is Dr. Jason J. Luke's office phone number?

The practice phone on file for Dr. Luke is (412) 432-5500.

What is Dr. Jason J. Luke's medical license number?

Dr. Luke holds Pennsylvania license 33440115.

What medical group is Dr. Jason J. Luke part of?

Dr. Luke is linked to University of Pittsburgh Physicians, Department of Radiology. Dmand AI links Dr. Luke to 1 more medical group.

Does Dr. Jason J. Luke accept Medicare?

Yes. CMS data shows Dr. Luke billed Medicare for 154 services in 2024.

What is Dr. Jason J. Luke's MIPS score?

Dr. Luke's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.

How many Medicare patients does Dr. Jason J. Luke see?

CMS counts 92 Medicare patients who saw Dr. Luke in 2024, with an average age of 71.

Is Dr. Jason J. Luke board certified?

Yes. Dr. Luke is board certified in medical oncology by the American Board of Internal Medicine.

Show 6 more questionsShow fewer questions

What services does Dr. Jason J. Luke bill to Medicare?

In 2024, Dr. Luke's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99232) and office visit, new patient (99205).

What drugs does Dr. Jason J. Luke prescribe most?

In 2019 Medicare Part D data, Dr. Luke's most prescribed drugs by claims were Levothyroxine Sodium.

Has Dr. Jason J. Luke received payments from drug or device companies?

CMS Open Payments shows $451,592 in general payments to Dr. Luke from 30 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Jason J. Luke been practicing?

Dr. Luke graduated from medical school in 2006, 20 years ago.

Does Dr. Jason J. Luke do research?

Dmand AI links 195 publications to Dr. Luke, published from 2011 to 2025. Dr. Luke has worked on 17 clinical trials.

Who does Dr. Jason J. Luke publish with?

Dr. Luke's most frequent co-authors are Thomas F. Gajewski (20 shared papers), Patrick Alexander Ott, MD (16 shared papers) and Steven J. Chmura (14 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)